Targeting CDK1 and copper homeostasis in breast cancer via a nanopolymer drug delivery system
Cell Biology and Toxicology · 2024
DOI: 10.1007/s10565-024-09958-2 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cell Biology and Toxicology, 2024. Verfasst von Nan Shang und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Urinary Surgery, the Fourth Affiliated Hospital of China Medical University, Shenyang, 110032, People's Republic of China. Hauptthemen laut MEDLINE: Copper, Breast Neoplasms, CDC2 Protein Kinase, Homeostasis. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 111 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Abstract (Originalsprache)
The prevalence of breast cancer (BRCA) is notable in the female population, being a commonly diagnosed malignancy, where the management of copper levels is crucial for treatment success. This research aims to explore the influence of copper homeostasis on BRCA therapy, with a specific focus on the role of Cyclin-Dependent Kinase 1 (CDK1) and its relationship to copper regulation. A novel thermosensitive hydrogel incorporating nanoparticles (NPs) was engineered to synergize with the chemotherapy drug vincristine (VCR) in inhibiting tumor growth and metastasis. Through a comprehensive approach involving bioinformatics analyses, in vitro experiments, and in vivo models, the study identified CDK1 as a significant factor in BRCA progression under copper homeostasis. MBVP-Gel, a novel thermosensitive hydrogel incorporating NPs, was developed to enhance the delivery of chemotherapy drugs and regulate copper homeostasis in breast cancer treatment. The MBVP-Gel, formulated with copper chelation and VCR NPs, effectively suppressed CDK1 expression, thereby restraining BRCA cell growth and metastasis while enhancing the therapeutic impact of VCR. This investigation offers fresh insights and experimental validation on the interaction between copper homeostasis and BRCA, providing a valuable foundation for refining future treatment strategies. These findings underscore the potential advantages of targeting copper homeostasis and CDK1 in enhancing BRCA therapy, setting the stage for individualized interventions and improved patient consequences.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Urinary Surgery, the Fourth Affiliated Hospital of China Medical University, Shenyang, 110032, People's Republic of China.
- Department of General Surgery, the Fourth Affiliated Hospital of China Medical University, Shenyang, 110032, People's Republic of China.
- Department of Thoracic and Cardiac Surgery, the Fourth Affiliated Hospital of China Medical University, Shenyang, 110032, People's Republic of China. cysong@cmu.edu.cn.
- Department of General Surgery, the Fourth Affiliated Hospital of China Medical University, Shenyang, 110032, People's Republic of China. liuxiaodan@cmu.edu.cn.
Zitieren
APA
Shang, N., Zhu, L., Li, Y., Song, C., & Liu, X. (2024). Targeting CDK1 and copper homeostasis in breast cancer via a nanopolymer drug delivery system. Cell Biology and Toxicology. https://doi.org/10.1007/s10565-024-09958-2
Vancouver
Shang N, Zhu L, Li Y, Song C, Liu X. Targeting CDK1 and copper homeostasis in breast cancer via a nanopolymer drug delivery system. Cell Biology and Toxicology. 2024. doi:10.1007/s10565-024-09958-2
BibTeX
@article{Shang2024,
author = {Shang, Nan and Zhu, Lisi and Li, Yan and Song, Chengyang and Liu, Xiaodan},
title = {Targeting CDK1 and copper homeostasis in breast cancer via a nanopolymer drug delivery system},
journal = {Cell Biology and Toxicology},
year = {2024},
doi = {10.1007/s10565-024-09958-2}
}
EUVIMED